Processa Pharmaceuticals (NASDAQ:PCSA) Publishes Investor Presentation
On February 11, 2025, Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) filed a Form 8-K with the United States Securities and Exchange Commission (SEC). In this filing, Processa Pharmaceuticals disclosed that a copy of a slide presentation, known as “Presentation Materials,” which the company intends to make available on its website, was attached to the Form 8-K as […]
On February 11, 2025, Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) filed a Form 8-K with the United States Securities and Exchange Commission (SEC). In this filing, Processa Pharmaceuticals disclosed that a copy of a slide presentation, known as “Presentation Materials,” which the company intends to make available on its website, was attached to the Form 8-K as […]
